RE
Remedent, Inc.
REMI · OTC
$0.00 +14.29% (+$0.00)
Market Cap $16.0K
P/E Ratio -
Div. Yield -
ROE 11.11%
Piotroski F-Score Moderate
4/9Valuation
100 /100
Cheap P/B 0.01x
P/S 0.02x
EV/FFO N/A
Growth
10 /100
Declining Book val. growth 19.24%
Rev. growth 1.43%
FCF growth N/A
Profitability
20 /100
Weak Net margin 27.83%
Op. margin 12.46%
FCF margin 13.23%
Quality
2 /100
Poor ROE 11.11%
ROA 5.00%
Asset turnover 0.18x
Debt
46 /100
Moderate Current ratio 0.33x
Int. coverage -97.24x
Debt/Equity 0.01x
Stability
16 /100
Unstable Rev. volatility 38.66%
EPS volatility 292.45%
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o REMI
Online
Sector
Healthcare
Industry
Medical - Instruments & Supplies
CEO
Guy De Vreese
Employees
3
Headquarters
Gent